Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Discussion April 8, 2020
    Dr Mahmoud Malas (San Diego, Calif). Congratulations on an excellent presentation. Dr Obi and Dr Henke from the University of Michigan studied bleeding and thrombotic complications associated with the use of direct oral anticoagulants compared with vitamin K antagonists or no anticoagulation after infrainguinal bypass.
  • Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions April 8, 2020
    Midterm outcomes after endovascular therapy (EVT) had been well-evaluated; however, 10-year outcomes after EVT are rarely reported.
    Tomonori Katsuki, Kyohei Yamaji, Seiichi Hiramori, Yusuke Tomoi, Yoshimitsu Soga, Kenji Ando
  • Survival after endovascular therapy in patients with ruptured thoracic aortic diseases: Results from the Global Registry for Endovascular Aortic Treatment Registry April 8, 2020
    The Global Registry for Endovascular Aortic Treatment is a prospective observational multicenter cohort registry of all Gore aortic endografts for a variety of aortic pathologies. The purpose of this study was to evaluate the outcome of the Conformable GORE TAG Thoracic Endoprosthesis and GORE TAG Thoracic Endoprosthesis devices for ruptured thoracic aortic syndromes.
    Kenneth Walsh, David J. O'Connor, Fred Weaver, Santi Trimarchi, Lifen Cao, Michael Wilderman, Anjali Ratnathicam, Kristen Cook, Massimo Napolitano, Gregory Simonian
  • Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures April 8, 2020
    Widespread adoption of direct oral anticoagulants (DOACs) for atrial fibrillation and venous thromboembolism treatment has resulted in peripheral bypass patients receiving therapeutic anticoagulation with DOACs postoperatively. This study was undertaken to evaluate patient outcomes after open peripheral bypass based on anticoagulation treatment.
    Andrea T. Obi, Jonathan R. Thompson, Robert J. Beaulieu, Danielle C. Sutzko, Nicholas Osborne, Jeremy Albright, Katherine A. Gallagher, Peter K. Henke
  • Safety and feasibility of transradial infrainguinal peripheral arterial disease interventions April 8, 2020
    Transradial access (TRA) has traditionally been favored for coronary interventions. Tools with up to 200 cm length now allow operators to treat infrainguinal peripheral arterial disease (PAD) using TRA. This study aims to assess the safety and feasibility of TRA infrainguinal interventions.
    Alex Sher, Raghuram Posham, Ageliki Vouyouka, Rahul Patel, Robert Lookstein, Peter L. Faries, Aaron Fischman, Rami Tadros
  • Incidence, predictors, impact, and treatment of vascular complications following transcatheter aortic valve implantation in a modern prospective cohort under real conditions April 7, 2020
    Vascular complications (VCs) occurring in TAVI procedures have frequently been reported in the past. Considering significant technical improvements in delivery systems and vascular closure devices, the goal of this study was to determine the incidence, impact, and prognostic factors of VCs in a recent real-world cohort.
    Quentin Langouet, Robert Martinez, Christophe Saint-Etienne, Reda Behlaj Soulami, Majid Harmouche, Michel Aupart, Hervé Le Breton, Jean-Philippe Verhoye, Thierry Bourguignon
  • Patients with Human Immunodeficiency Virus do not have Inferior Outcomes after Dialysis Access Creation April 7, 2020
    Despite improvements in treating human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), the risk of end-stage renal disease (ESRD) and need for long-term arteriovenous (AV) access for hemodialysis remain high in HIV-infected patients. Associations of HIV/AIDS with AV access creation complications have been conflicting. Our goal was to clarify short and long-term outcomes of […]
    Quinten G. Dicken, Thomas W. Cheng, Alik Farber, Scott R. Levin, Douglas W. Jones, Mahmoud B. Malas, Tze-Woei Tan, Denis Rybin, Jeffrey J. Siracuse